+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global External Defibrillator Market Report and Forecast 2023-2031

  • PDF Icon


  • 140 Pages
  • May 2023
  • Region: Global
  • Expert Market Research
  • ID: 5797936
The global external defibrillator market value was USD 3.5 billion in 2022, driven by the increasing incidence of cardiovascular diseases, aging population, and technological advancements in defibrillator devices across the globe. The market size is anticipated to grow at a CAGR of 8.80% during the forecast period of 2023-2031 to achieve a value of USD 7.5 billion by 2031.

External Defibrillator Introduction

External defibrillators are medical devices used to deliver an electrical shock to the heart in order to restore its normal rhythm in cases of cardiac arrest. They are widely used in hospitals, clinics, and emergency medical services (EMS) to treat patients experiencing sudden cardiac arrest.

There are two types of external defibrillators: automated external defibrillators (AEDs) and manual external defibrillators. AEDs are designed for use by non-medical personnel and are used in public places, while manual external defibrillators are used in hospitals and clinics by trained medical professionals.

The market for external defibrillators has seen significant growth in recent years due to the increasing incidence of cardiovascular diseases, aging population, and technological advancements in defibrillator devices. The growing demand for automated external defibrillators (AEDs) in public places such as airports, railway stations, and shopping malls is also contributing to the growth of the market.

The market is highly competitive, with several major players operating in the market. These players are focusing on product innovations, strategic partnerships, and acquisitions to maintain their market position and expand their product portfolios. In addition, the market is also witnessing a trend towards the development of wearable defibrillator devices, which can be used by patients at home.

Overall, the external defibrillator market is expected to continue to grow due to the increasing prevalence of cardiovascular diseases and the growing demand for AEDs in public places.

External Defibrillator Market Scenario

External defibrillators are medical devices used to deliver an electrical shock to the heart in order to restore its normal rhythm in cases of life-threatening cardiac arrhythmias. These devices are used in emergency settings such as hospitals, ambulances, and other healthcare facilities, as well as by first responders such as police and fire departments.

The global market for external defibrillators is primarily driven by an increasing incidence of sudden cardiac arrest (SCA) and the growing awareness about the importance of defibrillation during the golden hour to improve patient outcomes. Furthermore, the rising adoption of public access defibrillators (PADs) in public places and increasing government initiatives to support the use of these devices are also contributing to the growth of the market.

However, factors such as high cost of devices, stringent regulatory policies, and the need for regular maintenance and training of personnel to operate these devices are likely to restrain the market growth to some extent. Nevertheless, the introduction of technologically advanced and portable devices, increasing adoption of smart wearable defibrillators, and rising demand from emerging markets are expected to provide significant growth opportunities for the market in the coming years.

External Defibrillator Market Segmentations

Market Breakup by Product

  • Wearable Cardioverter Defibrillators
  • Implantable Cardioverter Defibrillators
  • Manual External Defibrillators

Automated External Defibrillators

  • Semi-Automated ED
  • Fully Automated ED

Market Breakup by End User

  • Pre-Hospital
  • Public Access Market
  • Hospital
  • Home Healthcare
  • Alternate Care Market
  • Others

Market Breakup by Region

North America

  • United States of America
  • Canada


  • United Kingdom
  • Germany
  • France
  • Italy
  • Others

Asia Pacific

  • China
  • Japan
  • India
  • Australia
  • Others

Latin America

  • Brazil
  • Argentina
  • Mexico
  • Others

Middle East and Africa

  • Saudi Arabia
  • United Arab Emirates
  • Nigeria
  • South Africa
  • Others

Key Trends in the External Defibrillator Market

Some key trends in the external defibrillator market are:
  • Increasing demand for automated external defibrillators (AEDs) for public access locations such as airports, schools, and stadiums
  • The emergence of wearable defibrillators that can be worn by patients at risk of sudden cardiac arrest
  • Integration of advanced technologies such as artificial intelligence and cloud-based connectivity for real-time monitoring and data analysis
  • Growing popularity of defibrillator rental and leasing services to provide cost-effective solutions for hospitals and clinics
  • Increasing adoption of defibrillator training programs for first responders, healthcare professionals, and laypeople to improve the chances of survival from cardiac arrest

External Defibrillator Market: Competitor Landscape

The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
  • Koninklijke Philips N.V
  • Stryker Corporation
  • ZOLL Medical Corporation
  • Nihon Kohden Corporation
  • Boston Scientific Corporation
  • Schiller AG
  • MS Westfalia GmbH
  • AMI Italia
  • Bexen Cardio
  • Silverline Meditech Pvt. Ltd
  • Mediana Co., Ltd
  • Shenzhen Mindray Bio-Medical Electronics
  • CU Medical Germany GmbH
  • BPL Medical Technologies
  • Dixion Vetrieb medizinischer Geräte GmbH
  • Bioevopeak Co., Ltd.

Table of Contents

1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage - Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global External Defibrillator Market Overview
3.1 Global External Defibrillator Market Historical Value (2016-2022)
3.2 Global External Defibrillator Market Forecast Value (2023-2031)
4 Global External Defibrillator Market Landscape
4.1 Global External Defibrillator Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global External Defibrillator Product Landscape
4.2.1 Analysis by Product
4.2.2 Analysis by End User
5 Global External Defibrillator Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global External Defibrillator Market Segmentation
6.1 Global External Defibrillator Market by Product
6.1.1 Market Overview
6.1.2 Wearable Cardioverter Defibrillators
6.1.3 Implantable Cardioverter Defibrillators
6.1.4 Manual External Defibrillators
6.1.5 Automated External Defibrillators Semi-Automated ED Fully Automated ED
6.2 Global External Defibrillator Market by End User
6.2.1 Market Overview
6.2.2 Pre-Hospital
6.2.3 Public Access Market
6.2.4 Hospital
6.2.5 Home Healthcare
6.2.6 Alternate Care Market
6.2.7 Others
6.3 Global External Defibrillator Market by Region
6.3.1 Market Overview
6.3.2 North America
6.3.3 Europe
6.3.4 Asia Pacific
6.3.5 Latin America
6.3.6 Middle East and Africa
7 North America External Defibrillator Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe External Defibrillator Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific External Defibrillator Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.6 Australia
9.7 Others
10 Latin America External Defibrillator Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa External Defibrillator Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Funding Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Regulatory Framework
16.1 Regulatory Overview
16.1.1 US FDA
16.1.2 EU EMA
16.1.5 Others
17 Supplier Landscape
17.1 Koninklijke Philips N.V.
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.1.5 Certifications
17.2 Stryker Corporation
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 ZOLL Medical Corporation
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 Nihon Kohden Corporation
17.4.1 Financial Analysis
17.4.2 Financial Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 Boston Scientific Corporation
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 ProgettiSrl
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 Schiller AG
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 MS Westfalia GmbH
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 AMI Italia
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10 Bexen Cardio
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
17.11 Silverline Meditech Pvt. Ltd.
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisitions
17.11.5 Certifications
17.12 Mediana Co., Ltd.
17.12.1 Financial Analysis
17.12.2 Product Portfolio
17.12.3 Demographic Reach and Achievements
17.12.4 Mergers and Acquisitions
17.12.5 Certifications
17.13 Shenzhen Mindray Bio-Medical Electronics
17.13.1 Financial Analysis
17.13.2 Product Portfolio
17.13.3 Demographic Reach and Achievements
17.13.4 Mergers and Acquisitions
17.13.5 Certifications
17.14 CU Medical Germany GmbH
17.14.1 Financial Analysis
17.14.2 Product Portfolio
17.14.3 Demographic Reach and Achievements
17.14.4 Mergers and Acquisitions
17.14.5 Certifications
17.15 BPL Medical Technologies
17.15.1 Financial Analysis
17.15.2 Product Portfolio
17.15.3 Demographic Reach and Achievements
17.15.4 Mergers and Acquisitions
17.15.5 Certifications
17.16 Dixion Vetrieb medizinischer Geräte GmbH
17.16.1 Financial Analysis
17.16.2 Product Portfolio
17.16.3 Demographic Reach and Achievements
17.16.4 Mergers and Acquisitions
17.16.5 Certifications
17.17 Bioevopeak Co., Ltd.
17.17.1 Financial Analysis
17.17.2 Product Portfolio
17.17.3 Demographic Reach and Achievements
17.17.4 Mergers and Acquisitions
17.17.5 Certifications
18 Global External Defibrillator Market - Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket

Companies Mentioned

  • Koninklijke Philips N.V.
  • Stryker Corporation
  • Zoll Medical Corporation
  • Nihon Kohden Corporation
  • Boston Scientific Corporation
  • Progettisrl
  • Schiller AG
  • Ms Westfalia GmbH
  • Ami Italia
  • Bexen Cardio
  • Silverline Meditech Pvt. Ltd.
  • Mediana Co. Ltd.
  • Shenzhen Mindray Bio-Medical Electronics
  • Cu Medical Germany GmbH
  • Bpl Medical Technologies
  • Dixion Vetrieb Medizinischer Geräte GmbH
  • Bioevopeak Co. Ltd.



Table Information